Maternal Use of Other Drugs than NSAIDs for Musculoskeletal Diseases and Infant Congenital Malformations

  • Bengt Källén


Muscle relaxing drugs do not seem to increase the risk for major malformations and the increased risk of minor anomalies is probably not causal but due to uneven reporting. Among drugs used for gout, some uncertainty exists for allopurinol with a possible association with a pattern of malformations but further data are needed to evaluate this. If true, the absolute risk appears to be low. Data on bisphosphonates during pregnancy are few but indicate no or low teratogenic risk. Further data are needed.


  1. Djokanovic N, Klieger-Grossmann C, Koren G. Does treatment with bisphosphonates endanger the human pregnancy? J Obstet Gynaecol Can. 2008;30:1146–8.CrossRefGoogle Scholar
  2. Green SB, Pappas AL. Effects of maternal biphosphonate use on fetal and neonatal outcomes. Am J Health Syst Pharm. 2014;71:2029–36.CrossRefGoogle Scholar
  3. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA: Publishing Sciences Group; 1977.Google Scholar
  4. Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C. Allopurinol use during pregnancy—outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for teratogenicity. PLoS One. 2013;8:e66637. Scholar
  5. Kozenko M, Grynspan D, Oluyomi T, Sitar D, Elliott AM, Chodirker BN. Potential teratogenic effects of allopurinol: a case report. Am J Med Genet A. 2011;155A:2247–52.CrossRefGoogle Scholar
  6. McKenna B, Mansfield JC. Safety of biphosphonates in women of child bearing age. Aliment Pharmacol Ther. 2009;29:1212–5.CrossRefGoogle Scholar
  7. Sokal A, Elefant-Amoura E, Leturcq T, Beghin D, Mariette X, Seror R. Biphosphonate during pregnancy: a prospective study. Ann Rheum Dis. 2016;75:93.CrossRefGoogle Scholar
  8. Stathopoulos PJ, Liakou GC, Katsalira A, Trovas G, Lyritis G, Papaioannou AN, Tournis S. The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones. 2011;10:280–91.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Bengt Källén
    • 1
  1. 1.Tornblad Institute for Comparative EmbryologyLund UniversityLundSweden

Personalised recommendations